Global X HealthTech ETF (NASDAQ:HEAL) Short Interest Up 596.8% in June

Global X HealthTech ETF (NASDAQ:HEAL) saw a significant growth in short interest during the month of June. As of June 15th, there was short interest totaling 37,633 shares, a growth of 596.8% from the May 31st total of 5,401 shares. Approximately 3.8% of the shares of the company are short sold. Based on an average daily trading volume, of 8,253 shares, the days-to-cover ratio is presently 4.6 days.

Global X HealthTech ETF Stock Performance

Shares of HEAL traded up $0.28 during midday trading on Friday, hitting $27.29. 1,368 shares of the stock traded hands, compared to its average volume of 11,378. The business’s 50 day moving average price is $25.40 and its two-hundred day moving average price is $26.74. The firm has a market capitalization of $27.29 million, a PE ratio of 42.80 and a beta of 1.12. Global X HealthTech ETF has a 1-year low of $23.00 and a 1-year high of $33.59.

Institutional Investors Weigh In On Global X HealthTech ETF

Several large investors have recently made changes to their positions in HEAL. Royal Bank of Canada raised its holdings in shares of Global X HealthTech ETF by 39.4% during the first quarter. Royal Bank of Canada now owns 2,603 shares of the company’s stock valued at $62,000 after buying an additional 736 shares during the last quarter. WT Wealth Management increased its position in Global X HealthTech ETF by 14.7% in the 1st quarter. WT Wealth Management now owns 101,116 shares of the company’s stock valued at $2,409,000 after acquiring an additional 12,945 shares during the period. EverSource Wealth Advisors LLC increased its position in Global X HealthTech ETF by 26,522.2% in the 4th quarter. EverSource Wealth Advisors LLC now owns 2,396 shares of the company’s stock valued at $70,000 after acquiring an additional 2,387 shares during the period. Farther Finance Advisors LLC bought a new stake in Global X HealthTech ETF during the 4th quarter valued at $111,000. Finally, Flow Traders U.S. LLC bought a new stake in Global X HealthTech ETF during the 3rd quarter valued at $368,000.

Global X HealthTech ETF Company Profile

An ETF that invests in companies at the intersection of healthcare and technology, targeting innovations in drug discovery, medical devices, consumer healthcare, and analytics.